Clinical trials for osteoporosis are designed to assess the safety and effectiveness of novel osteoporosis treatments. These trials play a crucial role in establishing whether these new treatments outperform existing options and provide substantial evidence to support their adoption within the wider population.

The primary aim of this particular study is to investigate the experiences of individuals diagnosed with osteoporosis who participate in a distinct clinical trial involving a medical intervention. The focus will be on closely monitoring the rates of trial completion and withdrawal among these participants.

Inclusion Criteria:

• Patient has been diagnosed with osteoporosis
• Patient has self-identified as planning to enroll in an observational clinical trial
• Patient is a minimum of 18 years or older

Exclusion Criteria:

• Pregnant or nursing patients
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Osteoporosis patients who are actively considering enrolling in an observational clinical trial, but have not yet completed enrollment and randomization.